Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online January 3, 2005.
Copyright & Usage
THE JOURNAL OF NUCLEAR MEDICINE
Author Information
- Christian Waldherr, MD1,
- Ingo K. Mellinghoff, MD1,2,
- Chris Tran, MS3,
- Benjamin S. Halpern, MD1,
- Nora Rozengurt, MD4,
- Arash Safaei1,
- Wolfgang A. Weber, MD1,
- David Stout, PhD1,
- Nagichettiar Satyamurthy, PhD1,
- Jorge Barrio, PhD1,
- Michael E. Phelps, PhD1,
- Daniel H. Silverman, PhD1,
- Charles L. Sawyers, MD1,2,3,5,6 and
- Johannes Czernin, MD1
- 1Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
- 2Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
- 3Howard Hughes Medical Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
- 4Department of Pathology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
- 5Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
- 6Molecular Biology Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- Harnessing Preclinical Molecular Imaging to Inform Advances in Personalized Cancer Medicine
- Noninvasive imaging of immune responses
- Fully Automated Production of Diverse 18F-Labeled PET Tracers on the ELIXYS Multireactor Radiosynthesizer Without Hardware Modification
- A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells
- Evaluation of the Genisys4, a Bench-Top Preclinical PET Scanner
- [18F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941
- In Vivo Imaging of Cell Proliferation Enables the Detection of the Extent of Experimental Rheumatoid Arthritis by 3'-Deoxy-3'-18F-Fluorothymidine and Small-Animal PET
- 3'-Deoxy-3'-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer
- Monitoring Tumor Response to Therapy with 18F-FLT PET
- Molecular Imaging: 18F-FDG PET and a Whole Lot More
- Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
- Kinetic Modeling of 3'-Deoxy-3'-18F-Fluorothymidine for Quantitative Cell Proliferation Imaging in Subcutaneous Tumor Models in Mice
- Imaging of Cell Proliferation: Status and Prospects
- Changes in Tumor Metabolism as Readout for Mammalian Target of Rapamycin Kinase Inhibition by Rapamycin in Glioblastoma
- Dynamic Small-Animal PET Imaging of Tumor Proliferation with 3'-Deoxy-3'-18F-Fluorothymidine in a Genetically Engineered Mouse Model of High-Grade Gliomas
- Preclinical Efficacy of the c-Met Inhibitor CE-355621 in a U87 MG Mouse Xenograft Model Evaluated by 18F-FDG Small-Animal PET
- Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors.
- Early Detection of Chemoradioresponse in Esophageal Carcinoma by 3'-Deoxy-3'-3H-Fluorothymidine Using Preclinical Tumor Models
- In vivo Biological Activity of the Histone Deacetylase Inhibitor LAQ824 Is detectable with 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography
- Positron Emission Tomography As an Imaging Biomarker
- Impact of Animal Handling on the Results of 18F-FDG PET Studies in Mice
- Chaperoning Drug Development with PET
- Reproducibility of 3'-Deoxy-3'-18F-Fluorothymidine MicroPET Studies in Tumor Xenografts in Mice